• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国国立卫生研究院肌肉减少症项目虚弱切点使用较不保守基础的一致性和预测效度

Agreement and Predictive Validity Using Less-Conservative Foundation for the National Institutes of Health Sarcopenia Project Weakness Cutpoints.

作者信息

Chiles Shaffer Nancy, Ferrucci Luigi, Shardell Michelle, Simonsick Eleanor M, Studenski Stephanie

机构信息

Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, Maryland.

出版信息

J Am Geriatr Soc. 2017 Mar;65(3):574-579. doi: 10.1111/jgs.14706. Epub 2016 Dec 26.

DOI:10.1111/jgs.14706
PMID:28024092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5357162/
Abstract

OBJECTIVES

To derive lean mass cutpoints based on a less-conservative Foundation for the National Institutes of Health (FNIH) Sarcopenia Project Weakness cutpoint for grip strength (Weak ) and to assess their agreement with European Working Group on Sarcopenia in Older People (EWGSOP) and prediction of incident slow walking and mortality.

DESIGN

Longitudinal analysis.

SETTING

Baltimore Longitudinal Study of Aging.

PARTICIPANTS

Individuals aged 65 and older (287 men, 258 women) with 2 to 10 years of follow-up.

MEASUREMENTS

Weakness was determined according to handgrip strength using a hand dynamometer, appendicular lean mass (ALM) using dual-energy X-ray absorptiometry, and walking speed according to 6-m usual pace walk speed. Analyses were performed using classification and regression tree analysis, Cohen's kappa, and Cox models.

RESULTS

Cutpoints derived from Weak for ALM (ALM ) were less than 21.4 kg in men and less than 14.1 kg in women and for ALM adjusted for body mass index (ALM/BMI ) were less than 0.725 in men and less than 0.591 in women. Kappas with EWGSOP were 0.65 for men and 0.75 for women for ALM and 0.34 for men and 0.47 for women for ALM/BMI . Men with Weak + ALM were twice as likely to develop slow walking as those not weak with normal ALM (Hazard ratio (HR) = 2.44, 95% confidence interval (CI) = 1.02-5.82). Under EWGSOP, men with weakness and low RALM were almost 3 times as likely to develop slow walking as those not weak with normal RALM (HR = 2.91, 95% CI = 1.11-7.62). Neither approach predicted incident slow walking in women.

CONCLUSION

The ALM cutpoints agree with EWGSOP and predict slow walking in men. Future studies should explore sex differences in the relationship between body composition and physical function and the effect of change in muscle mass on muscle strength and physical function.

摘要

目的

基于美国国立卫生研究院(FNIH)肌肉减少症项目中握力的较宽松虚弱切点(Weak)得出瘦体重切点,并评估其与欧洲老年人肌肉减少症工作组(EWGSOP)的一致性以及对发生行走缓慢和死亡率的预测。

设计

纵向分析。

设置

巴尔的摩纵向衰老研究。

参与者

65岁及以上个体(287名男性,258名女性),随访2至10年。

测量

使用握力计根据握力确定虚弱程度,使用双能X线吸收法测量四肢瘦体重(ALM),根据6米常规步速测量步行速度。使用分类和回归树分析、科恩kappa系数和Cox模型进行分析。

结果

根据Weak得出的男性ALM切点(ALM)小于21.4千克,女性小于14.1千克;根据体重指数调整后的ALM(ALM/BMI)切点,男性小于0.725,女性小于0.591。ALM与EWGSOP的kappa系数男性为0.65,女性为0.75;ALM/BMI与EWGSOP的kappa系数男性为0.34,女性为0.47。Weak + ALM的男性发生行走缓慢的可能性是ALM正常且不虚弱男性的两倍(风险比(HR)= 2.44,95%置信区间(CI)= 1.02 - 5.82)。在EWGSOP标准下,虚弱且RALM低的男性发生行走缓慢的可能性几乎是RALM正常且不虚弱男性的3倍(HR = 2.91,95%CI = 1.11 - 7.62)。两种方法均未预测出女性会发生行走缓慢。

结论

ALM切点与EWGSOP一致,并能预测男性行走缓慢。未来研究应探讨身体成分与身体功能关系中的性别差异以及肌肉量变化对肌肉力量和身体功能的影响。

相似文献

1
Agreement and Predictive Validity Using Less-Conservative Foundation for the National Institutes of Health Sarcopenia Project Weakness Cutpoints.美国国立卫生研究院肌肉减少症项目虚弱切点使用较不保守基础的一致性和预测效度
J Am Geriatr Soc. 2017 Mar;65(3):574-579. doi: 10.1111/jgs.14706. Epub 2016 Dec 26.
2
Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.与临床相关的肌肉无力和低瘦体重的标准及其与新发移动能力受损和死亡的纵向关联:美国国立卫生研究院(FNIH)肌少症项目的基础。
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):576-83. doi: 10.1093/gerona/glu012.
3
Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness.确定老年人有临床显著虚弱的低附肢瘦体质量切点。
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):567-75. doi: 10.1093/gerona/glu023.
4
Putative Cut-Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC Analysis.疑似肌少症成分的切点与不良健康结局的发生:SDOC 分析。
J Am Geriatr Soc. 2020 Jul;68(7):1429-1437. doi: 10.1111/jgs.16517. Epub 2020 Jul 7.
5
Anthropometric Cut Points for Definition of Sarcopenia Based on Incident Mobility and Physical Limitation in Older Chinese People.基于中国老年人新发移动能力和身体受限的肌少症定义的人体测量切点。
J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):935-40. doi: 10.1093/gerona/glv197. Epub 2015 Oct 30.
6
Physical function-derived cut-points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging.基于身体功能的加拿大老龄化纵向研究中肌少症和无力症诊断切点
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):985-999. doi: 10.1002/jcsm.12462. Epub 2019 Jul 15.
7
Do Different Ascertainment Techniques Identify the Same Individuals as Sarcopenic in the Canadian Longitudinal Study on Aging?不同的确定技术是否能在加拿大老龄化纵向研究中确定相同的肌少症个体?
J Am Geriatr Soc. 2021 Jan;69(1):164-172. doi: 10.1111/jgs.16823. Epub 2020 Sep 16.
8
Normative Data for Lean Mass Using FNIH Criteria in an Australian Setting.使用 FNIH 标准的澳大利亚人群瘦体重的参考值范围。
Calcif Tissue Int. 2019 Apr;104(4):475-479. doi: 10.1007/s00223-018-0506-1. Epub 2018 Dec 20.
9
Sarcopenia Definitions and Their Associations With Mortality in Older Australian Women.肌肉减少症定义及其与老年澳大利亚女性死亡率的关系。
J Am Med Dir Assoc. 2019 Jan;20(1):76-82.e2. doi: 10.1016/j.jamda.2018.10.016. Epub 2018 Dec 6.
10
Prevalence of Sarcopenia and Relationships Between Muscle and Bone in Indian Men and Women.肌肉减少症在印度男女中的流行情况以及肌肉与骨骼之间的关系。
Calcif Tissue Int. 2021 Oct;109(4):423-433. doi: 10.1007/s00223-021-00860-1. Epub 2021 May 9.

引用本文的文献

1
The association between muscle mass and change in physical functioning in older adults: a systematic review and meta-analysis of prospective studies.老年人肌肉量与身体功能变化之间的关联:前瞻性研究的系统评价和荟萃分析
Eur Geriatr Med. 2025 May 23. doi: 10.1007/s41999-025-01230-y.
2
The role of the circadian timing system in sarcopenia in old age: a scoping review.昼夜节律系统在老年人肌肉减少症中的作用:一项范围综述。
Eur Geriatr Med. 2025 Apr;16(2):447-460. doi: 10.1007/s41999-024-01129-0. Epub 2025 Jan 2.
3
Association among inflammaging, body composition, physical activity, and physical function tests in physically active women.身体活跃女性的炎症衰老、身体成分、身体活动与身体功能测试之间的关联。
Front Med (Lausanne). 2023 Jul 18;10:1206989. doi: 10.3389/fmed.2023.1206989. eCollection 2023.
4
Vertical Jump Tests: A Safe Instrument to Improve the Accuracy of the Functional Capacity Assessment in Robust Older Women.垂直跳跃测试:一种提高健壮老年女性功能能力评估准确性的安全工具。
Healthcare (Basel). 2022 Feb 8;10(2):323. doi: 10.3390/healthcare10020323.
5
Incident Impaired Cognitive Function in Sarcopenic Obesity: Data From the National Health and Aging Trends Survey.肌少症性肥胖患者认知功能障碍事件:来自国家健康老龄化趋势调查的数据。
J Am Med Dir Assoc. 2021 Apr;22(4):865-872.e5. doi: 10.1016/j.jamda.2020.09.008. Epub 2020 Oct 21.
6
Diurnal Salivary Cortisol in Sarcopenic Postmenopausal Women: The OsteoLaus Cohort.绝经后女性骨骼肌减少症患者的日间唾液皮质醇:OsteoLaus 队列研究。
Calcif Tissue Int. 2021 Nov;109(5):499-509. doi: 10.1007/s00223-021-00863-y. Epub 2021 May 18.
7
Reference Values for Skeletal Muscle Mass - Current Concepts and Methodological Considerations.骨骼肌质量的参考值 - 当前概念和方法学考虑。
Nutrients. 2020 Mar 12;12(3):755. doi: 10.3390/nu12030755.
8
Clinical Value of Muscle Mass Assessment in Clinical Conditions Associated with Malnutrition.肌肉量评估在与营养不良相关临床状况中的临床价值
J Clin Med. 2019 Jul 17;8(7):1040. doi: 10.3390/jcm8071040.
9
GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community.GLIM 营养不良诊断标准 - 全球临床营养界的共识报告。
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):207-217. doi: 10.1002/jcsm.12383.
10
Use of Raman spectroscopy to screen diabetes mellitus with machine learning tools.使用拉曼光谱结合机器学习工具筛查糖尿病。
Biomed Opt Express. 2018 Sep 26;9(10):4998-5010. doi: 10.1364/BOE.9.004998. eCollection 2018 Oct 1.

本文引用的文献

1
Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study.老年男性肌肉减少症共识定义的实用性评估:男性骨质疏松性骨折队列研究的观察结果
J Am Geriatr Soc. 2015 Nov;63(11):2247-59. doi: 10.1111/jgs.13788. Epub 2015 Oct 27.
2
Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older.肌少症现有定义对65岁及以上社区居住老年人跌倒前瞻性发生率的比较表现。
Osteoporos Int. 2015 Dec;26(12):2793-802. doi: 10.1007/s00198-015-3194-y. Epub 2015 Jun 12.
3
"Skeletal muscle function deficit" in a nationally representative British birth cohort in early old age.英国一个具有全国代表性的老年早期出生队列中的“骨骼肌功能缺陷”
J Gerontol A Biol Sci Med Sci. 2015 May;70(5):604-7. doi: 10.1093/gerona/glu214. Epub 2014 Nov 27.
4
An evidence-based comparison of operational criteria for the presence of sarcopenia.基于证据的肌少症存在的操作性标准比较。
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):584-90. doi: 10.1093/gerona/glu013.
5
Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.与临床相关的肌肉无力和低瘦体重的标准及其与新发移动能力受损和死亡的纵向关联:美国国立卫生研究院(FNIH)肌少症项目的基础。
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):576-83. doi: 10.1093/gerona/glu012.
6
Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness.确定老年人有临床显著虚弱的低附肢瘦体质量切点。
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):567-75. doi: 10.1093/gerona/glu023.
7
Grip strength cutpoints for the identification of clinically relevant weakness.握力切点用于识别临床相关的虚弱。
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):559-66. doi: 10.1093/gerona/glu011.
8
The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.FNIH 肌肉减少症计划:基本原理、研究描述、会议建议和最终估计。
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58. doi: 10.1093/gerona/glu010.
9
Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort.肌少症的定义:不同诊断标准对一大群中年人群中肌少症患病率的影响
Age (Dordr). 2013 Jun;35(3):871-81. doi: 10.1007/s11357-012-9384-z.
10
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.肌肉减少症:欧洲定义和诊断共识:老年人肌肉减少症欧洲工作组报告。
Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.